GB9626616D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9626616D0
GB9626616D0 GBGB9626616.8A GB9626616A GB9626616D0 GB 9626616 D0 GB9626616 D0 GB 9626616D0 GB 9626616 A GB9626616 A GB 9626616A GB 9626616 D0 GB9626616 D0 GB 9626616D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9626616.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symphar SA
Original Assignee
Symphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphar SA filed Critical Symphar SA
Priority to GBGB9626616.8A priority Critical patent/GB9626616D0/en
Publication of GB9626616D0 publication Critical patent/GB9626616D0/en
Priority to PCT/GB1997/003479 priority patent/WO1998028312A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
GBGB9626616.8A 1996-12-20 1996-12-20 Novel compounds Pending GB9626616D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9626616.8A GB9626616D0 (en) 1996-12-20 1996-12-20 Novel compounds
PCT/GB1997/003479 WO1998028312A1 (en) 1996-12-20 1997-12-18 Pharmaceutical aminophosphonic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9626616.8A GB9626616D0 (en) 1996-12-20 1996-12-20 Novel compounds

Publications (1)

Publication Number Publication Date
GB9626616D0 true GB9626616D0 (en) 1997-02-05

Family

ID=10804838

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9626616.8A Pending GB9626616D0 (en) 1996-12-20 1996-12-20 Novel compounds

Country Status (2)

Country Link
GB (1) GB9626616D0 (en)
WO (1) WO1998028312A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60139429D1 (en) 2000-02-16 2009-09-10 Smithkline Beecham Plc Pyrimidine-5-onderivatives as LDL-PLA2 inhibitors
CN1489596A (en) 2000-09-27 2004-04-14 �Ʒ� alpha-substituted beta-aminoethyl phosphonates
GB0024808D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
GB0025849D0 (en) 2000-10-23 2000-12-06 Smithkline Beecham Plc Novel compounds
NZ534794A (en) * 2002-02-11 2007-04-27 Ilex Products Inc Alpha-substituted arylalkyl phosphonate derivatives for lowering plasma levels of apo (a), lipoproteins and of total cholesterol
TW201307324A (en) 2010-12-06 2013-02-16 Glaxo Group Ltd Compounds
BR112014001665A2 (en) 2011-07-27 2017-02-14 Glaxo Group Ltd 2,3-dihydroimidazo [1,2-c] pyrimidin-5 (1h) -one compounds used as lp-plaz inhibitors
TW201321382A (en) 2011-07-27 2013-06-01 Glaxo Group Ltd Compounds
CN103906744A (en) 2011-09-01 2014-07-02 葛兰素集团有限公司 Novel crystal form
CA2899143A1 (en) 2013-01-25 2014-07-31 Glaxosmithkline Intellectual Property Development Limited Bicyclic pyrimidone compounds as inhibitors of lp-pla2
WO2014114248A1 (en) 2013-01-25 2014-07-31 Glaxosmithkline Intellectual Property Development Limited Compounds
EP2948452B1 (en) 2013-01-25 2017-08-09 GlaxoSmithKline Intellectual Property Development Limited 2,3-dihydroimidazol[1,2-c]pyrimidin-5(1h)-one based lipoprotein-associated phospholipase a2 (lp-pla2) inhibitors
WO2016012917A1 (en) 2014-07-22 2016-01-28 Glaxosmithkline Intellectual Property Development Limited 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2
WO2016012916A1 (en) 2014-07-22 2016-01-28 Glaxosmithkline Intellectual Property Development Limited 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2
CN112778331B (en) 2019-11-09 2022-07-05 上海赛默罗生物科技有限公司 Tricyclic dihydroimidazopyrimidinone derivatives, preparation method, pharmaceutical composition and application thereof
CN115304620A (en) 2021-05-07 2022-11-08 上海赛默罗生物科技有限公司 Pyrimidone derivatives, preparation method, pharmaceutical composition and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683996A5 (en) * 1992-03-05 1994-06-30 Symphar Sa aminophosphonates substituted derivatives, process for their preparation and pharmaceutical compositions containing them.
DE4433244A1 (en) * 1994-09-19 1996-03-28 Hoechst Ag Aminomethylphosphonic and aminomethylphosphinic acid derivatives and their use for the treatment of degenerative joint diseases
CH690264A5 (en) * 1995-06-30 2000-06-30 Symphar Sa aminophosphonates substituted derivatives, their preparation process and their use for preparing pharmaceutical compositions.

Also Published As

Publication number Publication date
WO1998028312A1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
EP0914330A4 (en) Novel compounds
EP0961618A4 (en) Novel compounds
EP0909181A4 (en) Novel compounds
GB9601067D0 (en) Novel compounds
EP0907376A4 (en) Novel compounds
AP9701047A0 (en) Novel compounds
GB9626616D0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9605381D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
EP0954525A4 (en) Novel compounds
GB9601068D0 (en) Novel compounds
EP0907377A4 (en) Novel compounds
GB9601066D0 (en) Novel compounds
GB9601099D0 (en) Novel compounds
GB9604581D0 (en) Novel compounds
GB9603655D0 (en) Novel compounds
GB9606649D0 (en) Novel compounds
GB9606199D0 (en) Novel compounds
GB9601095D0 (en) Novel compounds